
What makes 'superager' brains more resistant to aging?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
Researchers discover the immune system's ‘fountain of youth' - but it has a cost
Researchers have discovered the 'fountain of youth' for cells - but it comes with a big cost. Some people over 60 years old were found to have immune systems that appear to much younger in wear-and-tear, Mayo Clinic researchers announced Thursday. The immune system is what protects us from getting sick and promotes healing. With age, the immune system's ability to protect the body from infection and disease can wane. Young immune systems are constantly exposed to new bacteria and viruses, and previous research has shown that infant immune systems beat those of adults at fighting off the invaders. Researchers now say some have immune systems that don't match their age. "We observed that these patients have very young immune systems despite being in their 60s and 70s,' Dr. Cornelia Weyand, a Mayo Clinic rheumatologist and clinician-scientist, said in a statement. 'But the price they pay for that is autoimmunity.' Autoimmunity is what happens when the immune system mistakenly attacks healthy tissues and organs. There are more than 100 known autoimmune diseases, according to the Cleveland Clinic, including lupus, multiple sclerosis, psoriasis, celiac disease and Hashimoto's thyroiditis. Women are at a higher risk than men, thanks to genetic and hormonal differences, according to Stanford Medicine. Doctors discovered this anomaly in more than 100 older patients who went to the Minnesota clinic to receive treatment for a rare autoimmune disease known as giant cell arteritis. Giant cell arteritis is an inflammation of the lining of your arteries that can affect the arteries in your head, the clinic explained. Untreated, it can lead to blindness, an aortic aneurysm, and, less commonly, stroke. It frequently causes headaches, jaw pain and vision problems. What causes the disorder remains unknown. Studying the diseased tissue of these patients, the researchers found they had specialized cells in their immune system known as 'stem-like T cells.' The cells behave like young stem cells, which are critical for repairing and maintaining a healthy immune system. But, in this case, they were spreading the autoimmune disease. Going forward, the scientists hope to learn more about this link and what they observed from the patients. "Contrary to what one may think, there are benefits to having an immune system that ages in tandem with the body," Dr. Jörg Goronzy, a Mayo Clinic researcher on aging, said. "We need to consider the price to pay for immune youthfulness. That price can be autoimmune disease."


The Independent
2 hours ago
- The Independent
Stone Age humans were picky about which rocks they used for making tools, study finds
Early human ancestors during the Old Stone Age were more picky about the rocks they used for making tools than previously known, according to research published Friday. Not only did these early people make tools, they had a mental picture of where suitable raw materials were located and planned ahead to use them, traveling long distances. By around 2.6 million years ago, early humans had developed a method of pounding rocks together to chip off sharp flakes that could be used as blades for butchering meat. This allowed them to feast on large animals like hippos that gathered near a freshwater spring at the Nyayanga archaeological site in Kenya. 'But hippo skin is really tough" — and not all rocks were suitable for creating blades sharp enough to pierce hippo skin, said co-author Thomas Plummer, a paleoanthropologist at Queens College of the City University of New York. Co-author Emma Finestone of the Cleveland Museum of Natural History added: 'When we think about stone tools, not every rock is equal in terms of the quality of tools.' At the Nyayanga site, researchers found durable blades made of quartzite, a rock material that they traced to streambeds and other locations around 8 miles (13 kilometers) away. The new research appears in the journal Science Advances. 'This suggests they've got a mental map of where different resources are distributed across the landscape,' said co-author Rick Potts of the Smithsonian 's Human Origins Program. Previously, researchers had assumed the stones may have been found within just a mile or so of the freshwater spring site. The new study shows that 'these early humans were thinking ahead. This is probably the earliest time we have in the archaeological record an indication of that behavior,' said Eric Delson, a paleoanthropologist at the American Museum of Natural History, who was not involved in the research. The oldest previously known example of early human ancestors transporting raw materials for tool-making was about 600,000 years later than the Nyayanga site. Researchers said it's unclear who these early toolmakers were — whether members of the Homo genus or a related but extinct branch of the family tree, such as Paranthropus. Homo sapiens did not arise until much later, around 300,000 years ago. But the knack for seeking out the best raw materials to make simple technology dates back nearly 3 million years. 'We today are a species that's still technology-dependent — using tools to spread around the world and adapt to different environments,' said Finestone. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


Daily Mail
3 hours ago
- Daily Mail
The shocking side effect of ADHD drugs that could impact 22million Americans
People with ADHD who take medication may have a lower risk of dangerous behaviors, such as criminality, addiction and suicidal ideations, according to a new study. ADHD affects around five percent of children and 2.5 percent of adults globally, roughly 200 million people. It is linked to increased risks of suicidal behaviors, substance abuse, accidental injuries, transport accidents and criminality if people do not seek treatment. An international team of researchers wanted to establish if medication reduces these risks. Researchers from the University of Southampton and the Karolinska Institute in Sweden found that for two years of treatment with ADHD medication, people who took the drugs were less likely to experience these harmful incidents than those who didn't take medication. Around 22 million Americans are estimated to have ADHD and just over half of these are prescribed medication to manage their symptoms, which can include impulsiveness, disorganization and difficulty focusing. Medications are broadly classified into two main categories: stimulants and non-stimulants. Stimulants, the most common type, include methylphenidate and amphetamine-based medications that improve the transmission of the brain chemical dopamine which affects mood, motivation and movement. Non-stimulant options like atomoxetine, clonidine, and guanfacine can also be used, if stimulants are not effective or well tolerated. These help improve the transmission of norepinephrine, a hormone that helps with alertness and focus. Some of the best known brand names for ADHD medications include Adderall, Ritalin, Vyvanse, Focalin, Concerta, and Daytrana. Exactly why the condition occurs is not completely understood, but ADHD tends to run in families, suggesting genes may play a part. It is surprisingly common and as diagnosis has risen, so too have prescriptions for ADHD medication. From 2012 to 2022, the number of annual stimulant prescriptions increased by 57.9 percent, reaching 79.6 million, according to the DEA. In the new study, researchers examined multiple population and health records in Sweden linked by unique personal identification numbers assigned to every resident in the country. The team used a novel study design called a 'trial emulation' to simulate a trial using existing real-world data from 148,581 people with ADHD. Comparing those who had started any type of ADHD medication within three months of diagnosis with those who hadn't, they examined the records over the following two years. They found any form of medication reduced the first occurrence of four of the five incidents (with accidental injury being the exception) and all five outcomes when considering recurring incidents. Those taking stimulant medication were associated with the lowest incident rates, compared to non-stimulant medications. Methylphenidate was the most commonly prescribed drug, the researchers found. The likelihood was most reduced amongst people exhibiting a recurring pattern of behavior, such as multiple suicide attempts, numerous drug relapses or repeat offending. Medication didn't reduce the risk of a first-time accidental injury, but did reduce the risk of recurring ones. The study is the first of its kind to show the beneficial effect of ADHD medication on these broader clinical outcomes using a novel statistical method and data representative of all patients in routine clinical care from a whole country. 'This finding is consistent with most guidelines that generally recommend stimulants as the first-line treatment, followed by non-stimulants,' explains Dr Zheng Chang, senior author of the study from the Karolinska Institute. 'There is an ongoing discussion regarding whether methylphenidate [a stimulant medication for ADHD] should be included in the World Health Organization model list of essential medications, and we hope this research will help to inform this debate.' Co-senior author on the paper Samuele Cortese, a National Institute for Health and Care Research (NIHR) Research Professor at the University of Southampton added: 'The failure form clinical services to provide timely treatments that reduce these important outcomes represents a major ethical issue that needs to be addressed with urgency, with the crucial input of people with lived experience.'